Your SlideShare is downloading. ×
0
Report #13-008
Site License	
$18,000	

BUY THE
REPORT

REPORT OVERVIEW

Lab Budgets and Sources of
Funding in 2014: The Ma...
Report #13-008

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
BUY ...
STUDY SCOPE

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
BUY THE...
REPORT HIGHLIGHTS

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
B...
REPORT HIGHLIGHTS

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
B...
REPORT HIGHLIGHTS

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
B...
REPORT HIGHLIGHTS

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
B...
REPORT HIGHLIGHTS

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
B...
REPORT HIGHLIGHTS

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
B...
OVERVIEW

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
BUY THE
RE...
OVERVIEW

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
BUY THE
RE...
OVERVIEW

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
BUY THE
RE...
OVERVIEW

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
BUY THE
RE...
OVERVIEW

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
BUY THE
RE...
SAMPLE DATA

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
BUY THE...
SAMPLE DATA

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
BUY THE...
METHODOLOGY

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
BUY THE...
METHODOLOGY

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia

Knowle...
METHODOLOGY

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia

TOP OR...
PRICING

Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
BUY THE
REP...
Lab Budgets and Sources of Funding in 2014: The Market Outlook for
the United States, Europe and Asia
BUY THE
REPORT

Clic...
BUY THE
REPORT

Click here for
a complete list
of our
reports

n ABOUT BIOINFORMATICS LLC
Since our inception in 1994, Bio...
Upcoming SlideShare
Loading in...5
×

Report #13-008 - Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia

619

Published on

The overarching objective of this study was to assess sources of funding, the
competitive landscape and market opportunities in the United States, Europe
and Asia for life science tools companies. From the perspective of academic and
industrial labs, our goals were to:

1. Understand current sources of funding from government, industry, private foundation grants,
institutional funds, etc., their relative contribution to laboratory funding, and frequency of grant
submission.

2. Compare and contrast FY2013 (actual), and FY2014 (projected) average lab budgets in total by
broad product category, region, and market segment thus providing directional information for
FY2014.

3. Estimate scientists’ budget for purchases and anticipated purchases in instrumentation and
consumables, examining trends across key product categories.

4. Assess how optimistic scientists are regarding funding and the future of life science research.
The assessment is based upon an extensive review of secondary research sources to
better understand the scope of funding for the life sciences in the United States and
Europe, in addition to a primary research component involving a quantitative survey
of life scientists working in the United States, Europe and Asia.

Lab Budgets and Sources of Funding in 2014: The Market Outlook for the
United States, Europe and Asia explores projected 2014 lab budgets by
region and the implications of these findings for the life science tools market
in the coming year. This report provides an in-depth exploration of anticipated
lab spend for the year 2014. This primary and secondary research report
will enable suppliers to forecast demand, allocate resources and respond
appropriately to the economies of a global market.

Secondary Research
------------------------
We conducted extensive secondary research to gather available facts and
information from relevant research councils, funding agencies and private
funding sources in the United States and Europe to determine sources of
funding for scientific research.

To purchase this report as a non-sponsor, please contact:

Angela Fernandez
Marketing/Sales Coordinator
BioInformatics LLC
703.778.3080 ext. 14
reports@gene2drug.com
www.gene2drug.com

Published in: Business, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
619
On Slideshare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
8
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "Report #13-008 - Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia"

  1. 1. Report #13-008 Site License $18,000 BUY THE REPORT REPORT OVERVIEW Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia DECEMber 2013 ©2014 BioInformatics LLC www.gene2drug.com
  2. 2. Report #13-008 Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n Table of Contents n n Report Highlights........................................................................................................................................ 4 . n Overview................................................................................................................................................................ 10 . n Sample Data.........................................................................................................................................................15 n Methodology....................................................................................................................................................17 n Pricing.......................................................................................................................................................................20 . n Recent report titles..............................................................................................................................21 n ©2014 BioInformatics LLC Study Scope........................................................................................................................................................... 3 About Bioinformatics LLC............................................................................................................... 22 www.gene2drug.com 2 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  3. 3. STUDY SCOPE Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n STUDY SCope The overarching objective of this study was to assess sources of funding, the competitive landscape and market opportunities in the United States, Europe and Asia for life science tools companies. From the perspective of academic and industrial labs, our goals were to: 1. Understand current sources of funding from government, industry, private foundation grants, institutional funds, etc., their relative contribution to laboratory funding, and frequency of grant submission. 2. Compare and contrast FY2013 (actual), and FY2014 (projected) average lab budgets in total by broad product category, region, and market segment thus providing directional information for FY2014. 3. Estimate scientists’ budget for purchases and anticipated purchases in instrumentation and consumables, examining trends across key product categories. 4. Assess how optimistic scientists are regarding funding and the future of life science research. The assessment is based upon an extensive review of secondary research sources to better understand the scope of funding for the life sciences in the United States and Europe, in addition to a primary research component involving a quantitative survey of life scientists working in the United States, Europe and Asia. ©2014 BioInformatics LLC www.gene2drug.com 3 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  4. 4. REPORT HIGHLIGHTS Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n Report highlights Secondary Research Sources of Life Science Funding in the United States Overview n orecast F n ajor M Gross Expenditures on R&D for the Top Eight Countries in 2012, 2013 and 2014 Funding Sources of 2014 U.S. Life Science R&D Private Industry n omestic D n iotech B R&D Spend by PhRMA Member Companies 2001 to 2012 (in millions) Industry: Quarterly VC Investment (Q1 1995 through Q2 2013) U.S. Federal Government n ational N Institutes of Health Budget, 1998-2014 n llocation A n uccess S n IH N of the NIH FY2014 Budget Rates (Excluding ARRA) for NIH Funding, 1995-2012 Research Priorities for FY2014 n equested R ©2014 BioInformatics LLC FY2014 Budget Allocation for the NSF Directorate for Biological Sciences (BIO) www.gene2drug.com 4 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  5. 5. REPORT HIGHLIGHTS Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n Report highlights (continued) Academia and Other Sources n igher H Education R&D Expenditures by Source of Funds: FY2010-FY2011 n igher H Education R&D Expenditures by Source of Funds and R&D Field FY2011 n elected S Examples of Non-Profit Investment in Life Science R&D: GEN Top 20 Grant Giving Disease Foundations Summary and Outlook Sources of Life Science Funding in Europe Private Industry n &D R Spend of European Pharmaceutical Companies and Percent R&D Spent at the Preclinical Phase n umber N of Public European Biotech Companies and Amount Financed per Year n &D R Spend of European Biotech Companies n rug D Candidate Pipeline by Country, 2012 Public Funding n ife L Science Research Funding from the European Union n uropean E n orizon H ©2014 BioInformatics LLC Union 8th Framework Program for Research and Innovation 2020 Funding Budget Breakdown in Current Euros www.gene2drug.com 5 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  6. 6. REPORT HIGHLIGHTS Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n Report highlights (continued) n P7 F and Horizon 2020 Life Science Research Funding Levels n ublic P Life Science Research Funding in Germany n erman G Research Funding Process for Life Sciences n ublic P Life Science Research Funding Levels in Germany n ublic P Life Science Research Funding in France n rench F Research Funding Process for Life Sciences n ublic P Life Science Research Funding Levels in France n ublic P Life Science Research Funding in the United Kingdom n he T United Kingdom’s Research Funding Process for Life Sciences n ublic P Life Science Research Funding Levels in the United Kingdom Primary Research (United States, Europe and Asia) Laboratory Budgets n verage A Annual Research Budget by Market Segment for FY2012 to FY2014 (in USD) n nnual A n nnual A ©2014 BioInformatics LLC Research Budgets (in USD)—Academic Research Budgets (in USD)—Industrial www.gene2drug.com 6 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  7. 7. REPORT HIGHLIGHTS Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n Report highlights (continued) n ange R of Best Case and Worse Case Annual Research Budgets for FY2014 by Market Segment n ercent P n Y2013 F of FY2013 and FY2014 Research Budgets for Product Categories by Market Segment Lab Size and Expected Change in Lab Size in FY2014 by Market Segment n verage A Annual Research Budget per FTE by Market Segment for FY2013 and FY2014 n easons R Lab Size is Expected to Increase in FY2014 by Market Segment n easons R Lab Size is Expected to Decrease in FY2014 by Market Segment n ercent P of FY2013 and FY2014 Instrumentation Budgets for Specific Categories by Market Segment n ercent P of FY2013 and FY2014 Consumables Budgets for Specific Categories by Market Segment Laboratory Tools and Techniques n urrent C Use of Cell-Based Techniques by Market Segment n xpected E Change in Usage of Cell-Based Techniques n xpected E Usage of Cell-Based Techniques in FY2014—Academic n xpected E Usage of Cell-Based Techniques in FY2014—Industrial n lanned P FY2014 Cell-Based Analysis Equipment/Instrumentation Purchases by Market Segment ©2014 BioInformatics LLC www.gene2drug.com 7 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  8. 8. REPORT HIGHLIGHTS Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n Report highlights (continued) n urrent C Use of Genome-Based Techniques by Market Segment n xpected E Change in Usage of Genome-Based Techniques n xpected E Usage of Genome-Based Techniques in FY2014—Academic n xpected E Usage of Genome-Based Techniques in FY2014—Industrial n lanned P FY2014 Genome-Based Analysis Equipment/Instrumentation Purchases by Market Segment n urrent C Use of Protein-Based Techniques by Market Segment n xpected E Change in Usage of Protein-Based Techniques n xpected E Usage of Protein-Based Techniques in FY2014—Academic n xpected E Usage of Protein-Based Techniques in FY2014—Industrial n lanned P FY2014 Protein-Based Analysis Equipment/Instrumentation Purchases by Market Segment Sources of Funding n ources S of Support for FY2013 Research Budgets by Market Segment n ources S of Support for FY2014 Research Budgets by Market Segment n llocation A of Funding by Support Sources for FY2013 and FY2014 Research Budgets by Market Segment ©2014 BioInformatics LLC www.gene2drug.com 8 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  9. 9. REPORT HIGHLIGHTS Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n Report highlights (continued) Grants n umber N of Grant Applications per Fiscal Year by Market Segment n umber N of Different Grants Currently Supporting the Lab by Market Segment n verage A Value Associated with Each Grant by Market Segment (in USD) Customer Sentiment n ustomer C Sentiment Regarding Life Science Research Funding by Market Segment Region-Specific Demographics n evel L of Knowledge of Lab’s Budget by Market Segment n espondents’ R n rganization O n ob J ©2014 BioInformatics LLC Fiscal Year End by Market Segment Type by Market Segment Position by Market Segment www.gene2drug.com 9 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  10. 10. OVERVIEW Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n OVERVIEW Life science research is weathering an economically challenging time, exacerbated by the federal budget sequestration in the United States and by continued austerity in Europe. Grant money from all sources—both public and private—is increasingly difficult to obtain, and pharmaceutical spending on R&D has flattened following years of solid gains. Add to this mix a decreased level of reimbursement for molecular diagnostic testing and a slow recovery from the “Great Recession” to establish the external macro economic environment that has led to a new normal that is defined by increasingly constrained budgets. By contrast, developing nations in Asia—China in particular—are making significant investments in higher education, with a focus on science and technology, including biotechnology. In addition, many global pharmaceutical and biopharmaceutical firms are establishing research centers in these countries, taking advantage of lower cost structures and the new availability of a well-trained work force. In this complex macroeconomic environment, life science suppliers are seeking guidance as to how to anticipate and manage market trends in the United States, Europe and Asia. ©2014 BioInformatics LLC www.gene2drug.com 10 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  11. 11. OVERVIEW Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n Overview (continued) Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia explores projected 2014 lab budgets by region and the implications of these findings for the life science tools market in the coming year. This report provides an in-depth exploration of anticipated lab spend for the year 2014. This primary and secondary research report will enable suppliers to forecast demand, allocate resources and respond appropriately to the economies of a global market. Secondary Research We conducted extensive secondary research to gather available facts and information from relevant research councils, funding agencies and private funding sources in the United States and Europe to determine sources of funding for scientific research. ©2014 BioInformatics LLC www.gene2drug.com 11 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  12. 12. OVERVIEW Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n Overview (continued) Primary Research The survey was administered to life scientists who have budget authority and was designed to: ●n Detail current sources of funding ●n Estimate average lab budgets (2013 and 2014) ●n Determine lab budget allocation for instrumentation, consumables, overhead and services ● n Identify current usage of key techniques ●n Explore technique usage over the next 12 months ●n Identify key economic factors that are influencing lab operations ●n Gage the sentiments of life scientists regarding funding over the next 12 months ● n Assess likelihood to purchase new instrumentation over the next 12 months ●n Detail expected laboratory headcount over the next 12 months ●n Identify new and emerging technologies ©2014 BioInformatics LLC www.gene2drug.com 12 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  13. 13. OVERVIEW Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n Overview (continued) Product Categories Expected purchases in the following broad product categories will be covered in the report: Instrumentation ●n Instrumentation for cell-based analysis (flow cytometers, high content analyzers, all microscopes, high-throughput screening and analysis systems, etc.) ● n Instrumentation for genome analysis (thermal cyclers, real-time PCR instrumentation, microarray instrumentation, NGS, capillary electrophoresis, etc.) ● n Instrumentation for protein analysis (chromatography, electrophoresis, mass spectrometry, label-free detection, calorimetry, NMR, CD, etc.) ● n General lab equipment (water purification systems, incubators, freezers, centrifuges, etc.) ©2014 BioInformatics LLC www.gene2drug.com 13 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  14. 14. OVERVIEW Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n Overview (continued) Consumables ●n Kits and reagents for cell-based analysis (cell culture media and reagents, antibodies, cell biology kits, etc.) ● n Kits and reagents for genome analysis (enzymes, kits, ladders, nucleic acid purification and separation products, oligonucleotides [primers, RNAi], etc.) n Kits and reagents for protein purification and separation (chromatography media, electrophoresis matrices, protein ladders, etc.) n ©2014 BioInformatics LLC General laboratory chemicals, plasticware, glassware and disposables www.gene2drug.com 14 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  15. 15. SAMPLE DATA Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n sample data Expected FY2014 Instrumentation Budget Allocation by Product Category Other 4.1% Other 6.8% Genome analysis 19.1% General lab equipment 23.0% ©2014 BioInformatics LLC Expected FY2014 Consumables Budget Allocation by Product Category Protein analysis 27.0% Cell based analysis 24.1% Protein purification & separation kits & reagents 17.1% Genome analysis kits and reagents 25.0% Cell-based analysis kits and reagents 28.1% General laboratory supplies 25.8% www.gene2drug.com 15 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  16. 16. SAMPLE DATA Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n sample data Level of Customer Agreement by Region and Segment: “Life Science Funding is Increasingly Uncertain in My Country” 77% Academic (n=659) North America 63% Europe Asia 31% Industrial (n=412) Asia 12% 57% 4% 44% 39% 5% 56% 34% Highly Agree 5% 32% 51% North America Europe 21% 47% Agree or Neutral 20% Highly Disagree View Larger ©2014 BioInformatics LLC www.gene2drug.com 16 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  17. 17. METHODOLOGY Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n methodology – Primary Research This report, Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia, is based on responses to a 46-question online survey conducted by BioInformatics LLC (Arlington, Virginia, USA). 1,103 scientists from the United States, Europe and Asia met the qualification requirements of the study and participated in this survey between November 21 and December 3, 2013. All quantitative survey data presented in this report has been weighted by market segment (Academia & Government versus Industry) to more accurately represent the population of life scientists in each region as compared to the sample collected for this study. Weighted study demographics are presented. Original Share of Respondents ©2014 BioInformatics LLC 77% 77% 0.9950 23% 23% 1.0170 Academic 80% 63% 0.7901 20% 37% 1.8263 Academic 83% 40% 0.4808 Industrial Asia Academic Industrial Europe Weight Industrial United States Revised Share of Respondents 17% 60% 3.5695 www.gene2drug.com 17 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  18. 18. METHODOLOGY Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia Knowledge of Laboratory Budgets by Segment REGION BY SEGMENT 42% 48% I am extremely knowledgeable of my lab's budget North America (n=367) 19% 34% 36% 34% Europe (n=385) I am very knowledgeable of my lab's budget 33% 40% 21% I am somewhat knowledgeable of my lab's budget Asia (n=351) 18% 48% 27% Academic (n=666) Lighter Shade Industrial Industrial (n=437) View Larger ©2014 BioInformatics LLC Dark Shade Academic View Larger www.gene2drug.com 18 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  19. 19. METHODOLOGY Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia TOP ORGANIZATION BY SEGMENT Academic/University 68% Biopharmaceutical Company 30% Principal Investigator 16% 35% Professor/Assistant Professor/Teacher Pharmaceutical Company 28% Research Institute (non-profit) Government TOP JOB BY SEGMENT 2% 12% Staff Scientist 12% 9% Contract Research Organization 23% 20% 9% Lab Manager/ Director 22% 10% 4% Department Head Research Institute (for profit) University Medical Center 11% 7% View Larger ©2014 BioInformatics LLC 18% Academic (n=636) Industrial (n=363) Post Doctoral Fellow 14% 2% Academic (n=586) Industrial (n=346) View Larger www.gene2drug.com 19 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  20. 20. PRICING Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT n ACT NOW Due to popular demand, we are making this report available to a wider audience following early access by the study’s syndicating sponsors. In addition, new purchasing options are available for region-specific sections of the report. This report will only be available electronically with a site license, and a complimentary dataset in Excel (regularly a $1,200 value) will be included with your order. n nited U n urope E n sia A States Only (Primary & Secondary Research) $6,200 Only (Primary & Secondary Research) $6,200 Only (Primary Research) n nited U States, Europe & Asia (Primary & Secondary Research) $6,200 $18,000 With your purchase of this report, we invite you to set up a meeting with our report team of scientific and business analysts. We can answer any questions you may have about the study results and we can share with you what we believe to be the significant trends affecting your market. ©2014 BioInformatics LLC www.gene2drug.com 20 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  21. 21. Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia BUY THE REPORT Click here for a complete list of our reports n Recent report titles: NGS Library Prep Market Scan Digital Marketing to Life Scientists: Social Media and Email Best Practices October 2013 Life Science Instrumentation: Brand Performance June 2013 The Market for Primary Cells & Stem Cell –Derived Cells May 2013 Enhancing the Customer Experience March 2013 Best Practices for Advertising to Life Scientists ©2014 BioInformatics LLC November 2013 February 2013 www.gene2drug.com 21 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  22. 22. BUY THE REPORT Click here for a complete list of our reports n ABOUT BIOINFORMATICS LLC Since our inception in 1994, BioInformatics LLC has provided critical market intelligence to leading companies serving the life science, medical and pharmaceutical industries. We support clients across the entire market spectrum—from scientific research to diagnostics and therapeutics—providing high-level management with market insights. Our published reports allow marketing professionals to share in the results of broad-based market studies that provide access to high-quality research at an affordable price. Our custom research is tailored to the specific needs of the companies’ executive management. For more information about BioInformatics’ product and service offerings, please visit our website at www.gene2drug.com, call 703.778.3080 x22, or email g.thompson@gene2drug.com ©2014 BioInformatics LLC www.gene2drug.com 22 @2013 BioInformatics, LLC n www.gene2drug.com n Report #13-005
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×